sciencebriefs
8:40in productionCh. 1 · The stain that wasn’t/ 8:40 · ceiling 15 min
Neuroscience · Medicine

Blood–brain barrier

Paul Ehrlich

Paul Ehrlich discovered the blood–brain barrier by missing it.

Ehrlich’s intravenous dye experiments revealed selective absence of brain staining — but he misinterpreted it as passive under-uptake. His student Goldmann’s 1913 intracerebrospinal injection proved compartmentalization. The barrier was attributed to blood vessels, not a membrane. Ehrlich never believed in it. The term came later, from Lina Stern.

NeuroscienceMedicineNeuroscienceMedicineChemistryNeuroscience across the network →
Chapters & takeaways4
  1. 0:40
    The stain that wasn’t

    Ehrlich saw unstained brains after intravenous dye — but thought the brain just ignored the dye.

  2. 2:08
    The discoverer who rejected his discovery

    He illuminated the barrier without believing it existed.

  3. 3:41
    The experiment that flipped the route

    Goldmann proved compartmentalization in 1913 — and the barrier was attributed to blood vessels, not a membrane.

  4. 5:26
    A name borrowed from silence

    The term 'blood–brain barrier' came later — from Lina Stern, not Ehrlich or Goldmann.

Worth your time?

Yes. Study the whole thing.

4/ 5
What works
  • Demonstrates how experimental route determines interpretation
  • Shows that conceptual framing lags evidence by decades
  • Highlights role of student replication in correcting mentor error
What does not
  • Ehrlich claimed a barrier existed
  • Ehrlich believed in the barrier
  • The term 'blood–brain barrier' originated with Ehrlich or Goldmann
Study it if
  • historians of science
  • neuroscientists studying drug delivery
  • anyone who assumes discovery is belief
Skip it if
  • clinicians seeking current BBB models
  • students needing mechanistic explanations
The written brief1 min read

What the work claims

Ehrlich’s work did not claim a barrier. It illuminated one only in retrospect. The conceptual framing — that blood vessels themselves constituted the barrier — emerged after his misinterpretation.

How it was done

Ehrlich injected aniline dyes intravenously and observed selective absence of brain staining under microscopy. Goldmann later injected the same dyes into the cerebrospinal fluid in 1913.

What holds up

Goldmann’s 1913 experiment demonstrated compartmentalization: dye in CSF stained brain but not body; intravenous dye stained body but not brain.

What does not

Ehrlich did not claim a barrier existed. He interpreted absent staining as passive under-uptake. He never believed in the barrier.

Why it matters beyond the lab

It shows how terminology lags evidence — and how a phrase (‘blood–brain barrier’) coined decades later retroactively organises earlier, contradictory observations.

Is it worth your time

Yes — it reveals how foundational observations can mislead even their discoverer, and how experimental design (route of administration) alone resolved a conceptual impasse.

Same field · Neuroscience4 of 45
13:00
Ion channelIon channels are pore-forming proteins that let ions cross cell membranes at very high rates without spending metabolic energy, and their electrical behaviour had been studied indirectly for decades before anyone saw their shape. In 1998, Roderick MacKinnon's laboratory solved the X-ray crystal structure of a bacterial potassium channel, KcsA, revealing a selectivity filter of backbone oxygen atoms arranged to mimic the water shell around a potassium ion, letting it pass while excluding the smaller sodium ion. The work, which earned MacKinnon a share of the 2003 Nobel Prize in Chemistry, turned a long-standing theoretical mechanism into a structure that could be looked at directly.
9:19
Golgi apparatusCamillo GolgiCamillo Golgi discovered the Golgi apparatus in 1898 using osmium dichromate staining on barn owl Purkinje cells. He named it 'apparato reticolare interno' and asserted it was a real, unique cellular component. Initial scepticism held that it was an optical illusion. The finding was not firmly established until electron microscopy emerged ~50 years later. It revealed a new intracellular structure but gave no insight into its function, mechanism, or universality.
13:00
Snake venomSnake venom is best understood not as a single toxic substance but as a mixture of enzymes and peptides, each aimed at a specific point in how nerves signal muscles. The neurotoxins among them are the clearest case: their molecular targets are well established even where the broader classification of venom types is still argued over.
13:00
EnkephalinEnkephalin, identified in 1975, was the first molecule shown to be a natural, body-made substance that acts on the same opioid receptors that morphine and other opiate drugs target. It comes in two closely related five-amino-acid forms, met-enkephalin and leu-enkephalin, both produced from a single precursor gene. The discovery opened onto a wider family: beta-endorphin, characterised in 1976, dynorphins, traced to a gene identified in 1983, and endomorphins found in the 1990s, together acting on four distinct opioid receptor types and shaping pain, stress, feeding and the rewarding effects of substances including alcohol and nicotine.
Up next in Science

British Doctors Study

· 11:03

A single mail-out to British doctors in 1951 settled the smoking debate — but only for men, and only for death.

Play nextBack to Neuroscience
11:03